Tag Archives: generic

Express Scripts New Solution Integrates Prescription Discount Card Pricing with Benefits

Continuation in rising costs of specialty drugs and maybe accelerate in next 1-2 years: Randy Vogenberg

Express Scripts has launched a new solution that aims to integrate prescription discount card pricing into members’ existing benefits

Sam’s Club Accelerating Implementation of Healthcare Strategy

The Care Accelerator launched last year which was only the beginning of Sam’s Club’s increased involvement in health care

Civica Rx Finding Success in Supply Generic Drugs

Civica Rx’s mission is to ensure that essential generic medications are accessible and affordable

It’s a New Year, But Omnicare Continues to Disappoint

Continuing weak margins due to staffing struggles, recent generic introductions, and decreasing reimbursements remain the leading drivers of the poor results

Oncology Biosimilars: Opportunity or Not?

Oncology Biosimilars: Opportunity or Not? VBCC – April 2016, Vol 7, No 3 – Employers’ Perspective F. Randy Vogenberg, PhD, RPh, Partner Access Market Intelligence Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA The United States has the largest biologic drugs market and high prices for biologics, such as monoclonal antibodies, therapeutic proteins, immunomodulators, and […]

Top Healthcare Market Trends

Knowsource.com Announces Transition to Access Market Intelligence

  Many of the 2016 top healthcare market trends began back in 2012-to-2014, and finally emerged more clearly in 2015 for commercially insured populations. This year Access Market Intelligence identifies four (4) major themes emerging that creates the top trends to watch in 2016 into 2017. Themes encapsulating the Top Trends are Macro Issues Trending […]

Blues Plans Can Use Various Tactics to Mitigate Generic Drug Price Inflation

Blues Plans Can Use Various Tactics to Mitigate Generic Drug Price Inflation, Published in The AIS Report on Blue Cross Blue Shield Plans, V14, Number 7 July 2015         Randy Vogenberg, Ph.D., Partner, Access Market Intelligence notes that the FDA has cited “quality and manufacturing issues” as “a major reason for drug shortages. Most […]